Investigation of the antioxidant characteristics of a new tryptamine derivative of securinine and its influence on seizure activity in the brain in experimental epilepsy

Neurochemical Journal

Volumn 5, Issue 3, 2011, Pages 208-214

  Neganova, M E ^a   Blik, V A ^b   Klochkov, S G ^a   Chepurnova, N E ^b   Shevtsova, E F ^a  

^a INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

antioxidants; derivative of securinine; lipid peroxidation; models of epilepsy; neuroprotectors

Indexed keywords

EID: 80052506433     PISSN: 18197124     EISSN: 18197132     Source Type: Journal    
DOI: 10.1134/S1819712411030056     Document Type: Article

References (21)

1. Mukhin, K. Yu., Petrukhin, A. S., and Vasil'eva, I. A., Psikhiatriya i Psikhofarmakoterapiya, 2004, vol. 6, no. 1, pp. 14-20.
2. Zenkov, L. R. and Prityko, A. G., Farmakorezistentnye epilepsii (Drug-Resistant Epilepsies), Moscow: MED-press-inform, 2003.
3. Wasterlain, C. G and Chen, J. W, Status Epilepticus: mechanisms and management, Wasterlain, C. G. and Treiman, D. M., Eds., Cambridge: MIT Press, 2006, pp. 11-16.
4. Chepurnov, S. A., Chepurnova, N. E., Redkozubova, O. M., and Saakyan, S. A., Usp. Fiziol. Nauk, 2005, vol. 36, no. 1, pp. 68-84.
5. Kovcés, R., Schuchmann, S., Gabriel, S., Kann, O., Kardos, J., and Heinemann, U., J. Neurophysiol., 2002, vol. 88, pp. 2909-2918.
6. Levy, S. L., Burnham, W. M., Bishai, A., and Hwang, P. A., Can. J. Neurol. Sci, 1992, vol. 19, pp. 201-203.
7. Tupeev, I. R., Kryzhanovskii, G. N., Nikushkin, E. V., Bordyukov, M. M., and Yuzefova, S. M., Byul. Eksper. Biol. i Med, 1993, vol. 116, no. 10, pp. 362-364.
8. Artyukhov, V. G. and Nakvasina, M. A., Biologicheskie membrany: strukturnaya organizatsiya, funktsii, modifikatsiya fiziko-khimicheskimi agentami (Biological Membranes: Structural Organization, Functions, and Modification by Physicochemical Agents), Voronezh: Izd. VGU, 2000.
9. Gulcin, I., Mshvidadze, V., and Gepdiremen, A., Phytomedicine, 2006, no. 13, pp. 343-351.
10. Perez, C. A., Wei, Y., and Guo, M., Biochemistry, 2009, vol. 103, no. 3, pp. 326-332.
11. Velisek, L., Kubova, H., Pohl, M., Stankova, L., Mares, P., and Schikverova, R., Pharmacol., 1992, vol. 346, pp. 588-591.
12. Yonekawa, W. D., Harvey, J. K., and Woodbury, D. M., J. Pharmacol. Exp. Ther., 1980, vol. 214, pp. 589-593.
13. Jope, R. S., Morrisett, R. A., and Snead, O. C., Exp. Neurol., 1986, vol. 91, pp. 471-480.
14. Millán-Plano, S., Piedrafita, E., Miana-Mena, F. J., and Fuentes-Broto, L., J. Mol. Sci., 2010, no. 11, pp. 312-328.
15. Shin, E. J., Ko, K. H., Kim, W. K., Chae, J. S., and Yen, T. P, Neurochem. Int., 2008, vol. 52, no. 6, pp. 1134-1147.
16. Williams, T. I., Lynn, B. C., Markesbery, W. R., and Lovell, M. A., Neurobiol. Aging., 2006, vol. 27, pp. 1094-1099.
17. Oliveira, M. S., Furian, A. F., Royes, L. F., Fighera, M. R., de Carvalho, Myskiw, J., Fiorenza, N. G., and Mello, C. F., Neuroscience, 2004, vol. 128, pp. 721-728.
18. Tejada, S., Sureda, A., Roca, C., Gamundí, A., and Esteban, S., Brain Res. Bull., 2007, vol. 71, pp. 372-375.
19. Klochkov, S. G., Afanas'eva, S. V., and Grigor'ev, V. V., Chem. Nat. Compounds, 2008, vol. 44, pp. 197-202.
20. Pan, J., Chang, Q., Wang, X., Son, Y., Zhang, Z., Chen, G., Luo, J., Bi, Y., Chen, F., and Shi, X., Chem. Res. Toxicol., 2010, vol. 23, pp. 568-577.
21. Klochkov, S., Shevtsova, E. F., Afanas'eva, S. V., Neganova, M. E., and Serkova, T. P., Eur. Neuropsychopharmacol., 2008, no. 18, pp. S514-S515.